# Readline

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/readline

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.szreadline.com
- Total disclosed funding: $128M
- Latest round: Series C (Feb 22, 2025)
- Investors on record: 12

## About

Established in 2017 and based in Shenzhen, China, Readline operates as an immobilized enzyme catalyst technology application services provider that provides innovative products and business solutions in the health, consumption, and agriculture industries. The company has bases located in Gansu, Zhuhai, and the UK. The company has acquired the IFRC Halal Award. In February 2025, Readline closed series C funding from returning investors CoStone Capital and Green Pine Capital Partners. The company has developed a green bio-intelligence platform ReBioHub, which covers biocomputing and AI, green chemistry, genetic engineering, enzyme engineering, cell engineering, fermentation engineering, intelligent automation, and quality research. Its products are divided into six series, which include effective skin care, nutrition and health, animal health, biomedicine, green agriculture and biomaterials, including myostatin, hexadecanedioic acid and derivatives, and collagen tripeptide, etc. The company generates revenue by providing synthetic biotechnology application services. The company will use the funds for setting up production bases in Changde and Shaoguan and improving production.

## Funding rounds

- Series C, Feb 22, 2025, $70M — Green Pine Capital Partners, CoStone Capital
- Series B, Apr 13, 2023 — SYN Capital
- Series B, Dec 9, 2022, $43M — Oriental Fortune Capital, Green Pine Capital Partners, CoStone Capital, Zhuhai Jinhang Industrial Investment, Changde Caixin Financial Holding Group, Zhuhai Gree Group, Xinshang Investment, Changde Kaiyuan Industrial Investment Fund
- Series A, Dec 4, 2020, $15M — Oriental Fortune Capital, Leaguer Group, Deepshire Investment Management, Qianhai Hongfu
- Angel, Jun 5, 2019 — Deepshire Investment Management

## Investors

- Deepshire Investment Management (https://capitalatlas.ai/funds/deepshire-investment-management) — Angel, Series A
- Oriental Fortune Capital (https://capitalatlas.ai/funds/oriental-fortune-capital) — Series A, Series B
- Leaguer Group (https://capitalatlas.ai/funds/leaguer-group) — Series A
- Qianhai Hongfu — Series A
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series B, Series C
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B, Series C
- Zhuhai Jinhang Industrial Investment — Series B
- Changde Caixin Financial Holding Group — Series B
- Zhuhai Gree Group — Series B
- Xinshang Investment (https://capitalatlas.ai/funds/xinshang-investment) — Series B
- Changde Kaiyuan Industrial Investment Fund — Series B
- SYN Capital — Series B